×
Alphatec Holdings EBITDA 2010-2025 | ATEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Alphatec Holdings ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Alphatec Holdings EBITDA 2010-2025 | ATEC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Alphatec Holdings ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$184.1B
Intuitive Surgical (ISRG)
$172.5B
IDEXX Laboratories (IDXX)
$51B
Edwards Lifesciences (EW)
$46B
Alcon (ALC)
$43.5B
IQVIA Holdings (IQV)
$32.7B
DexCom (DXCM)
$31.7B
Mettler-Toledo (MTD)
$27B
STERIS (STE)
$24.1B
Waters (WAT)
$17.2B
SONOVA HOLDING (SONVY)
$16.8B
Hologic (HOLX)
$15B
Penumbra (PEN)
$10B
Sysmex ADR (SSMXY)
$8.4B
Masimo (MASI)
$8.4B
Globus Medical (GMED)
$8.1B
Teleflex (TFX)
$5.3B
Glaukos (GKOS)
$5.1B
TransMedics (TMDX)
$4.3B
Integer Holdings (ITGR)
$3.7B
LivaNova (LIVN)
$2.9B
Veracyte (VCYT)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.3B
Artivion (AORT)
$2B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.8B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B
Integra LifeSciences Holdings (IART)
$1.1B
Pulse Biosciences (PLSE)
$1.1B